About Pragya Pandey

Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.

When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.


Recent Articles By Pragya Pandey

: TER |  News, Ratings, and Charts

Should You Buy the Dip in Teradyne?

Shares of Teradyne (TER) have retreated 32.7% in price over the past month despite the company recording robust revenue and earnings growth in its last quarter. So, given that TER has lowered its outlook for its fiscal year 2022, should one scoop up its shares at their current price level? Let's discuss.
: MPWR |  News, Ratings, and Charts

Should You Buy the Dip in Monolithic Power Systems?

The shares of semiconductor-based power electronics provider Monolithic Power Systems (MPWR) have plunged 20.6% in price over the past six months. In addition, they are trading below their 50-day and 200-day moving averages. So, will the stock be able to regain its momentum amid the semiconductor chip production crisis? Read on. Let's find out.
: SEDG |  News, Ratings, and Charts

Down 25% in the Past 3 Months, is Now a Good Time to Scoop Up Shares of SolarEdge Technologies?

The shares of SolarEdge Technologies (SEDG) have lost momentum due in-part to uncertainties related to President Biden’s proposed Build Back Better bill and declining investor confidence in the space. So, is it wise to scoop up SEDG’s shares now, given that the company is currently trading at a lofty valuation? Read on to learn our view.
: FFIV |  News, Ratings, and Charts

Should You Buy the Dip in F5 Networks?

F5 Inc. (FFIV) has made consistent product and services advances and expanded its market reach over the past months. So, let's evaluate if it would be wise to buy the dip in the stock now? Read on.
: PII |  News, Ratings, and Charts

Is Polaris Industries a Good Recreational Vehicle Stock to Own in 2022?

The shares of the leading sports vehicle manufacturer, Polaris Inc. (PII), have fallen nearly 17.9% in price over the past nine months. But given that the company reported robust revenue growth in its last reported quarter, can the stock regain its momentum? Read on. Let's find out.
: EPD |  News, Ratings, and Charts

2 High-Yield MLPs to Add to Your Watchlist

Master limited partnerships (MLPs) are recognized for their unique tax structure, which exempts them from paying corporate taxes. So, given analysts' expectations for the Treasury yield curve over the coming months, we believe high-yield MLP stocks Enterprise Products (EPD) and MPLX LP (MPLX) could be great additions to one’s watchlist. Read on to learn more.
: ZION |  News, Ratings, and Charts

Is Zions Bancorporation a Good Regional Bank Stock to Own in 2022?

Zions Bancorporation (ZION) has maintained stable momentum over the past year coupled with impressive profitability. However, given the company's bleak growth prospects, is it worth adding its stock to one’s portfolio now? Read on to learn our view.
: PAYC |  News, Ratings, and Charts

Is Paycom a Good Human Capital Management (HCM) Software Stock to Buy?

Leading human capital management software provider Paycom Software (PAYC) reported strong top-line growth in its last reported quarter. However, its stock has slumped nearly 38% in price over the past month. So, is it worth betting on the stock now, considering the recent sell-off in the tech sector? Let's discuss.
: LUKOY |  News, Ratings, and Charts

3 of the Safest Stocks to Buy in February: Crane, Lukoil, and Albertsons

Many investors foresee a continued market meltdown triggered by the continuing spread of COVID-19, upcoming rate hikes, and high inflation. Hence, we think it is prudent to bet on safe stocks Lukoil PJSC (LUKOY), Albertsons Companies (ACI), and Crane Co. (CR) owing to their resilience to market fluctuations.
: MDRX |  News, Ratings, and Charts

Does Allscripts Healthcare Solutions Deserve a Place in Your Portfolio?

The shares of electronic health records company Allscripts Healthcare (MDRX) have generated solid momentum over the past months on the back of earnings and revenue growth across all the company’s business segments in its last reported quarter. So, with increasing demand for healthcare services globally, is it worth adding the stock to one’s portfolio? Let's discuss.
Page generated in 1.2878 seconds.